Ramprasad Reddy has his skin the game; he has made some timely bets with a nifty strategy for Aurobindo.

The Novartis portfolio includes top-selling brand TOBI Podhaler, a drug prescribed for symptomatic relief to patients suffering from cystic...

Daiichi Sankyo, the beleaguered Japanese owner of the drug maker, may be tempted to debate whether it is time to rechristen its Indian unit.

Sanofi-Aventis which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to fin...

The news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...

Sanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.

The board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...

Glenmark Pharmaceuticals on Tuesday said it has incorporated a company in Romania for its speciality pharmaceutical business and hopes to a...

Mylan Laboratories agreed to buy Merck KGaA’s generic-drug unit for 4.9 billion euros ($6.7 billion) in cash to become the world’s third-la...